Hostname: page-component-7bb8b95d7b-nptnm Total loading time: 0 Render date: 2024-09-13T08:11:50.789Z Has data issue: false hasContentIssue false
  • English
  • Français

Risk Factors for the Development of Clostridium difficile-Associated Diarrhea During a Hospital Outbreak

Published online by Cambridge University Press:  21 March 2023

Alain Thibault ,
Mark A. Miller  and
Christina Gaese
Alain Thibault
Affiliation:
Department of Microbiology, Montreal General Hospital, Montreal, Quebec, Canada
Mark A. Miller*
Affiliation:
Department of Microbiology, Montreal General Hospital, Montreal, Quebec, Canada
Christina Gaese
Affiliation:
Department of Microbiology, Montreal General Hospital, Montreal, Quebec, Canada
*
Department of Microbiology, Montreal General Hospital, 1650 Cedar Ave., Montreal, Quebec, Candda H3G 1A4
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To evaluate the risk factors associated with a nosocomial outbreak of Clostridium difficile-associated diarrhea.

Design:

Case-control study with two control groups.

Setting:

University-affiliated urban hospital.

Patients:

A convenience sample of 26 patients was chosen out of a total of 78 hospitalized patients with C difficile-associated diarrhea, defined as the presence of diarrhea and a positive C difficile cytotoxin assay or stool culture. Twenty-six controls were matched for age, gender, ward, and date of admission; 18 additional controls were matched to surgical patients for date and ward of admission, as well as for the type of surgical procedure performed.

Results:

Significant risk factors for the development of C difficile-associated diarrhea were gastrointestinal surgery (exposure odds ratio [EOR] = 7.9, p= .004, 95% confidence interval [CI]= 1.9, 35), use of neomycin (EOR= 15.6, p=.012, 95% CI=1.7, 92), clindamycin (EOR=15.6, p=.005, 95% CI=1.7, 92), metronidazole (EOR=5.7,p=.02,95%CI= 1.4, 25), and excess antibiotic use (mean number of antibiotics = 4.2 versus 1.4, p<.00005). The presence of systemic disease and the use of antacids or immunosuppressive drugs were similar in cases and controls. In surgical patients, no specific antibiotic could be linked to C difficile-associated diarrhea because of uniform perioperative antibiotic use. There was a significant difference in the number of antibiotics administered to cases and controls (mean = 3.1 versus 1.9, p< .005).

Conclusions:

The results suggest that control of nosocomial C difficile-associated diarrhea may be attained by minimizing the administration of antibiotics, avoidance of high-risk antibiotics, and having a high index of suspicion of C difficile-associated diarrhea in patients who develop diarrhea after gastrointestinal surgery. Perioperative administration of metronidazole, when given with other antibiotics, failed to protect against the development of C difficile-associated diarrhea.

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 12 , Issue 6 , June 1991 , pp. 345 - 348
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Tedesco, FJ. Pseudomembranous colitis: pathogenesis and therapy. Med Clin N Am. 1982;66:655–664.CrossRefGoogle ScholarPubMed
2. Bartlett, JG. Clostridium difficile: clinical considerations. Rev Infect Dis. 1990;12:S243–S251.CrossRefGoogle ScholarPubMed
3. Gerding, DN. Disease associated with Clostridium difficile infection. Ann Intern Med. 1989;110:255–257.CrossRefGoogle ScholarPubMed
4. Silva, J Jr. Update on pseudomembranous colitis. West J Med. 1989;151:644–648.Google ScholarPubMed
5. McFarland, LV, Mulligan, ME, Kwok, MS, Stamm, WE. Nosocomial acquisition of Clostridium dificile-associated infection. N Engl J Med. 1989;320:204–210.CrossRefGoogle ScholarPubMed
6. Johnson, S, Peterson, LR, Gerding, DN. Intravenousmetronidazole and Clostridium dificile-associated diarrhea or colitis. J Infect Dis. 1989;160:1087.CrossRefGoogle ScholarPubMed
7. Rothman, KJ. Modern Epidemiology. Boston, Mass: Little, Brown, and Co.; 1986.Google Scholar
8. Pierce, PF, Wilson, R. Antibiotic-associated pseudomembranous colitis: an epidemiologic investigation of a cluster of cases. J Infect Dis. 1982;145:269–274.CrossRefGoogle ScholarPubMed
9. Aronsson, B, Möllby, R. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiologic data from Sweden, 1980-1982. J Infect Dis. 1985;151:476–481.CrossRefGoogle Scholar
10. Gerding, DN, Olson, MM, Peterson, LR, et al. Clostridium difficile-associated diarrhea and colitis in adults. Arch Intern Med. 1986;146:95–100.CrossRefGoogle ScholarPubMed
11. McFarland, LY, Surawicz, CM, Stamm, WE. Risk factors for Clostridium difficile carriage and C difficile-associated diarrhea in a cohort of hospitalized patients. J Infect Dis. 1990;162:678–684.CrossRefGoogle Scholar
12. Knudson, AG. Mutation and cancer: statistical study of retinoblastoma. Proc Nat Acad Sci USA. 1971;68:820–823.CrossRefGoogle ScholarPubMed
13. Mulligan, ME. Epidemiology of Clostridium difficile-induced intestinal disease. Rev Infect Dis. 1984;6:S222–S228.CrossRefGoogle ScholarPubMed